AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2021
Nov 3, 2021
30237_dirs_2021-11-03_f74b0712-26af-4fbf-914c-6c4d153e21df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-11-01
Reporting Person: Schechter Adam H (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-01 | Common Stock | M | 2007 | — | Acquired | 13295 | Direct |
| 2021-11-01 | Common Stock | F | 886 | $288.78 | Disposed | 12409 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-01 | Restricted Stock Unit | $ | M | 2007 | Disposed | Common Stock (2007) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: Stock withholding to satisfy tax withholding obligations.
F3: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on November 1, 2020.
F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30
Director's Dealing
2026
Mar 30
Director's Dealing
2026
Mar 30